These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Infrequency of urinary excretion of beta-aminoisobutyric acid by healthy humans. Evered DF; Barley JF Clin Chim Acta; 1978 Mar; 84(3):339-46. PubMed ID: 639325 [TBL] [Abstract][Full Text] [Related]
7. [Genetic dimorphism in beta-aminoisobutyric acid excretion in patients with atherosclerosis of the coronary artery and in groups at risk for atherosclerosis in the Lithuanian population]. Spitsyn VA; Stakishaĭtis DV; Preĭksha RA Genetika; 1993 Nov; 29(11):1861-70. PubMed ID: 8307373 [TBL] [Abstract][Full Text] [Related]
8. [Ecogenetic aspects of the study of phenotypes and levels of beta-aminoisobutyric acid excretion]. Spitsyn VA; Afanas'eva IS; Alekseeva NV Genetika; 1993 Nov; 29(11):1871-7. PubMed ID: 8307374 [TBL] [Abstract][Full Text] [Related]
9. Beta-aminoisobutyric acid (BAIB) excretion in urine of residents of eight communities in the states of Michoacán and Oaxaca, Mexico. Lasker GW; Mast J; Tashian R Am J Phys Anthropol; 1969 Jan; 30(1):133-6. PubMed ID: 5780373 [No Abstract] [Full Text] [Related]
10. Elevated urinary excretion of beta-aminoisobutyric acid and exposure to inorganic lead. Farkas WR; Fischbein A; Solomon S; Buschman F; Borek E; Sharma OK Arch Environ Health; 1987; 42(2):96-9. PubMed ID: 3579372 [TBL] [Abstract][Full Text] [Related]
11. Complex segregation analysis of the locus for beta-aminoisobutyric acid excretion (BAIB). Simpson SP; Morton NE Hum Genet; 1981; 59(1):64-7. PubMed ID: 10819024 [TBL] [Abstract][Full Text] [Related]
12. Urinary pseudouridine and beta-aminoisobutyric acid in patients with low grade urothelial tumours. Relations between excretion and tumour recurrence. Nyholm KK; Sjolin KE; Wolf H; Hammer M; Knudsen J; Stahl D; Nielsen HR Biomedicine; 1976 May; 25(3):85-7. PubMed ID: 949520 [TBL] [Abstract][Full Text] [Related]
14. Urinary iron in patients with sickle cell anamia. Washington R; Boggs DR J Lab Clin Med; 1975 Jul; 86(1):17-23. PubMed ID: 1151137 [TBL] [Abstract][Full Text] [Related]
15. Number and maturation of reticulocytes in various genotypes of thalassaemia as assessed by flow cytometry. Khuhapinant A; Bunyaratvej A; Tatsumi N; Pribwai M; Fucharoen S Acta Haematol; 1994; 91(3):119-25. PubMed ID: 8091932 [TBL] [Abstract][Full Text] [Related]
16. Growth and pubertal development in transfusion-dependent children and adolescents with thalassaemia major and sickle cell disease: a comparative study. Soliman AT; elZalabany M; Amer M; Ansari BM J Trop Pediatr; 1999 Feb; 45(1):23-30. PubMed ID: 10191589 [TBL] [Abstract][Full Text] [Related]
17. Urinary iron excretion in thalassaemia after desferrioxamine administration. Seshadri R; Colebatch JH; Fisher R Arch Dis Child; 1974 Mar; 49(3):195-9. PubMed ID: 4825624 [TBL] [Abstract][Full Text] [Related]
19. Pseudouridine and beta-aminoisobutyric acid excretion in urine: diagnostic and prognostic value. Kvist E; Sjølin KE Scand J Urol Nephrol; 1990; 24(4):283-5. PubMed ID: 2274752 [TBL] [Abstract][Full Text] [Related]
20. [Inhibitory effect of D-cycloserine on beta-aminoisobutyric acid and beta-alanine metabolism. I. Increase of urinary excretion of beta-aminoisobutyric acid and beta-alanine of patients with pulmonary tuberculosis by administration of D-cycloserine, and elucidation of its mechanism]. Yasumitsu T Kekkaku; 1973 May; 48(5):177-87. PubMed ID: 4732657 [No Abstract] [Full Text] [Related] [Next] [New Search]